RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 67 filers reported holding RECRO PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 3,510,000 | $6,318,000 | 5.40% |
| Cowen Prime Advisors LLC | 4,162,500 | $7,493,000 | 3.15% |
| Athyrium Capital Management, LP | 2,202,420 | $3,964,000 | 1.41% |
| AWM Investment Company, Inc. | 5,081,901 | $9,147,000 | 1.18% |
| Parkman Healthcare Partners LLC | 671,817 | $1,209,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 799,841 | $1,440,000 | 0.18% |
| Rubric Capital Management LP | 1,076,587 | $1,938,000 | 0.07% |
| TITLEIST CAPITAL, LLC | 180,093 | $324,000 | 0.06% |
| Clear Harbor Asset Management, LLC | 266,972 | $481,000 | 0.06% |
| Frontier Wealth Management LLC | 64,605 | $2,701,000 | 0.03% |